Budget Amount *help |
¥5,460,000 (Direct Cost: ¥4,200,000、Indirect Cost: ¥1,260,000)
Fiscal Year 2014: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2013: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2012: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
|
Outline of Final Research Achievements |
In the present study, we chased the fate of pancreatic beta cells by utilizing inducible cell labeling system. In alloxan-induced diabetic mice, the human GLP-1 receptor agonist liraglutide restored function and mass of beta cells. Liraglutide increased beta cell proliferation and decreased beta cell death, but did not induce neogenesis of beta cells.
|